The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income MarginBy mariocazombo76@gmail.com / March 17, 2025
Charles River Laboratories: Retained Earnings, ROE, And Debt Management Will Shape Its Future Amid Weak Demand February 1, 2025 / CRL, Daniel Mellado / By mariocazombo76@gmail.com
Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential February 6, 2025 / Daniel Mellado, MEDP / By mariocazombo76@gmail.com